All Companies

Companysort icon Description Status Initial Date
<a href="/venture-capital/all-companies/black-duck-software-inc">Black Duck Software, Inc.</a> Providing the world’s only end-to-end platform for OSS Logistics. Private 2004 View Profile
<a href="/venture-capital/all-companies/bizo">Bizo</a> Private 2008 View Profile
<a href="/venture-capital/all-companies/bind-therapeutics-inc">BIND Therapeutics, Inc.</a> Developing Accurins, its novel targeted therapeutics. Public 2007 View Profile
<a href="/venture-capital/all-companies/bg-medicine-inc">BG Medicine, Inc.</a> Developing and delivering diagnostic solutions to aid in the clinical management of heart failure and related disorders. Public 2000 View Profile
<a href="/venture-capital/all-companies/aveo-pharmaceuticals-inc">AVEO Pharmaceuticals, Inc.</a> Discovering, developing and commercializing cancer therapeutics. Public 2003 View Profile
<a href="/venture-capital/all-companies/avedro-inc">Avedro, Inc.</a> Advancing the science and technology of corneal crosslinking and refractive correction. Private 2009 View Profile
AudioLogic, Inc. High performance digital signal processing systems Acquired 1993 View Profile
<a href="/venture-capital/all-companies/aspect-medical-systems-inc">Aspect Medical Systems, Inc.</a> Pioneer and global market leader in brain monitoring and measurement products Acquired 1995 View Profile
<a href="/venture-capital/all-companies/antigenics">Antigenics</a> Technology and products to treat cancers, infectious diseases, and autoimmune disorders Public 1994 View Profile
Anesta Corporation Powerful drug system to control the severe pain of end stage cancer Acquired 1986 View Profile
<a href="/venture-capital/all-companies/alvine-pharmaceuticals-inc">Alvine Pharmaceuticals, Inc.</a> Developing biologics to target autoimmune/inflammatory diseases. Private 2006 View Profile
<a href="/venture-capital/all-companies/alere-medical-incorporated">Alere Medical Incorporated</a> Internet-based medical monitoring systems for patients with chronic diseases Acquired 1998 View Profile
<a href="/venture-capital/all-companies/agios-pharmaceuticals-inc">Agios Pharmaceuticals, Inc.</a> Discovering and developing novel drugs to treat cancer and inborn errors of metabolism. Public 2007 View Profile
<a href="/venture-capital/all-companies/affinnova-inc">Affinnova, Inc.</a> Improving innovation and marketing success rates. Private 2000 View Profile
<a href="/venture-capital/all-companies/adolor-corporation">Adolor Corporation</a> Discovery, development and commercialization of prescription pain management products Public 1996 View Profile
<a href="/venture-capital/all-companies/adnexus-therapeutics">Adnexus Therapeutics</a> Developing new class of therapeutic compounds. Acquired 2002 View Profile
<a href="/venture-capital/all-companies/accuri-cytometers-inc">Accuri Cytometers, Inc.</a> Developing and manufacturing revolutionary, low-cost, high-performance flow cytometers for researchers. Acquired 2008 View Profile
<a href="/venture-capital/all-companies/acceleron-pharma-inc">Acceleron Pharma, Inc.</a> Discovering, developing and commercializing novel protein therapeutics for cancer and rare diseases. Public 2004 View Profile